The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-10-31

AUTHORS

Mark Evans, Zoë Welsh, Sara Ells, Alexander Seibold

ABSTRACT

IntroductionGlycated haemoglobin A1c (HbA1c) is the established standard measurement for assessment of glycaemic control in people with diabetes. Here we report on a meta-analysis of real-world observational studies on the impact of flash continuous glucose monitoring on glycaemic control as measured by HbA1c.MethodsA total of 271 studies were identified in our search, of which 29 contained data reporting changes in HbA1c over periods from 1 to 24 months that could be used in a statistical analysis. Our meta-analysis focuses on observed change in HbA1c at either 2, 3 or 4 months, in adult or paediatric subjects, as well as a longitudinal analysis up to 12 months in adult subjects. These data were drawn from 25 of the studies identified in our initial search. These reported HbA1c data up to 12 months in a total of 1723 participants with type 1 diabetes (T1D) or type 2 diabetes (T2D) using the FreeStyle Libre® flash glucose monitoring system.ResultsOverall mean change in laboratory HbA1c across study subjects at 2–4 months was − 0.55% (95% CI − 0.70, − 0.39). Amongst the 1023 adults, mean change in HbA1c was − 0.56% (95% CI − 0.76, − 0.36); for the 447 children and adolescents, mean change in HbA1c was − 0.54% (95% CI − 0.84, − 0.23). Based on regression analysis, the degree of change in HbA1c correlated with the initial HbA1c of the study population. A longitudinal analysis in adult subjects (n = 1276) shows that HbA1c fell within the first 2 months and changes were sustained up to 12 months. No significant differences were detected between T1D and T2D.ConclusionThe meta-analysis reported here confirms that starting the FreeStyle Libre system as part of diabetes care results in a significant and sustained reduction in HbA1c for adults and children with T1D and for adults with T2D.FundingAbbott Diabetes Care. More... »

PAGES

83-95

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-019-00720-0

DOI

http://dx.doi.org/10.1007/s13300-019-00720-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1122231011

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31673972


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wellcome Trust/MRC Institute of Metabolic Science, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.24029.3d", 
          "name": [
            "Wellcome Trust/MRC Institute of Metabolic Science, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "Mark", 
        "id": "sg:person.0752030520.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752030520.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abbott Diabetes Care, Witney, Oxfordshire, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Abbott Diabetes Care, Witney, Oxfordshire, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Welsh", 
        "givenName": "Zo\u00eb", 
        "id": "sg:person.011536100730.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011536100730.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abbott Diabetes Care, Witney, Oxfordshire, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Abbott Diabetes Care, Witney, Oxfordshire, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ells", 
        "givenName": "Sara", 
        "id": "sg:person.012333461330.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012333461330.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abbott Diabetes Care, Wiesbaden, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Abbott Diabetes Care, Wiesbaden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seibold", 
        "givenName": "Alexander", 
        "id": "sg:person.015373573342.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015373573342.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00125-012-2708-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036534764", 
          "https://doi.org/10.1007/s00125-012-2708-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-016-0223-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024814077", 
          "https://doi.org/10.1007/s13300-016-0223-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.3758/bf03195354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025666111", 
          "https://doi.org/10.3758/bf03195354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-018-1218-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106472592", 
          "https://doi.org/10.1007/s00592-018-1218-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-10-31", 
    "datePublishedReg": "2019-10-31", 
    "description": "IntroductionGlycated haemoglobin A1c (HbA1c) is the established standard measurement for assessment of glycaemic control in people with diabetes. Here we report on a meta-analysis of real-world observational studies on the impact of flash continuous glucose monitoring on glycaemic control as measured by HbA1c.MethodsA total of 271 studies were identified in our search, of which 29 contained data reporting changes in HbA1c over periods from 1 to 24\u00a0months that could be used in a statistical analysis. Our meta-analysis focuses on observed change in HbA1c at either 2, 3 or 4\u00a0months, in adult or paediatric subjects, as well as a longitudinal analysis up to 12\u00a0months in adult subjects. These data were drawn from 25 of the studies identified in our initial search. These reported HbA1c data up to 12\u00a0months in a total of 1723 participants with type\u00a01 diabetes (T1D) or type\u00a02 diabetes (T2D) using the FreeStyle Libre\u00ae flash glucose monitoring system.ResultsOverall mean change in laboratory HbA1c across study subjects at 2\u20134\u00a0months was \u2212\u20090.55% (95% CI \u2212\u20090.70, \u2212\u20090.39). Amongst the 1023 adults, mean change in HbA1c was \u2212\u20090.56% (95% CI \u2212\u20090.76, \u2212\u20090.36); for the 447 children and adolescents, mean change in HbA1c was \u2212\u20090.54% (95% CI \u2212\u20090.84, \u2212\u20090.23). Based on regression analysis, the degree of change in HbA1c correlated with the initial HbA1c of the study population. A longitudinal analysis in adult subjects (n\u2009=\u20091276) shows that HbA1c fell within the first 2\u00a0months and changes were sustained up to 12\u00a0months. No significant differences were detected between T1D and T2D.ConclusionThe meta-analysis reported here confirms that starting the FreeStyle Libre system as part of diabetes care results in a significant and sustained reduction in HbA1c for adults and children with T1D and for adults with T2D.FundingAbbott Diabetes Care.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-019-00720-0", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "real-world observational study", 
      "glycaemic control", 
      "observational study", 
      "adult subjects", 
      "flash continuous glucose monitoring", 
      "glucose monitoring", 
      "flash glucose monitoring system", 
      "flash glucose monitoring", 
      "FreeStyle Libre system", 
      "longitudinal analysis", 
      "continuous glucose monitoring", 
      "glucose monitoring system", 
      "diabetes care", 
      "clinical trials", 
      "pediatric subjects", 
      "study population", 
      "sustained reduction", 
      "study subjects", 
      "care results", 
      "Meta-Analysis", 
      "HbA1c", 
      "laboratory HbA1c", 
      "diabetes", 
      "initial search", 
      "months", 
      "FreeStyle Libre", 
      "adults", 
      "significant differences", 
      "T1D", 
      "regression analysis", 
      "degree of change", 
      "subjects", 
      "total", 
      "children", 
      "statistical analysis", 
      "ResultsOverall", 
      "study", 
      "control", 
      "trials", 
      "care", 
      "hemoglobin", 
      "changes", 
      "standard measurements", 
      "adolescents", 
      "participants", 
      "observed changes", 
      "population", 
      "reporting changes", 
      "monitoring", 
      "search", 
      "assessment", 
      "period", 
      "analysis", 
      "data", 
      "differences", 
      "impact", 
      "reduction", 
      "people", 
      "types", 
      "degree", 
      "results", 
      "part", 
      "monitoring system", 
      "system", 
      "measurements", 
      "Libre"
    ], 
    "name": "The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies", 
    "pagination": "83-95", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1122231011"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-019-00720-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31673972"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-019-00720-0", 
      "https://app.dimensions.ai/details/publication/pub.1122231011"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_802.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-019-00720-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-019-00720-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-019-00720-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-019-00720-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-019-00720-0'


 

This table displays all metadata directly associated to this object as RDF triples.

169 TRIPLES      21 PREDICATES      95 URIs      83 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-019-00720-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Na78c984d32dc46e586aff01b1d783656
4 schema:citation sg:pub.10.1007/s00125-012-2708-9
5 sg:pub.10.1007/s00592-018-1218-8
6 sg:pub.10.1007/s13300-016-0223-6
7 sg:pub.10.3758/bf03195354
8 schema:datePublished 2019-10-31
9 schema:datePublishedReg 2019-10-31
10 schema:description IntroductionGlycated haemoglobin A1c (HbA1c) is the established standard measurement for assessment of glycaemic control in people with diabetes. Here we report on a meta-analysis of real-world observational studies on the impact of flash continuous glucose monitoring on glycaemic control as measured by HbA1c.MethodsA total of 271 studies were identified in our search, of which 29 contained data reporting changes in HbA1c over periods from 1 to 24 months that could be used in a statistical analysis. Our meta-analysis focuses on observed change in HbA1c at either 2, 3 or 4 months, in adult or paediatric subjects, as well as a longitudinal analysis up to 12 months in adult subjects. These data were drawn from 25 of the studies identified in our initial search. These reported HbA1c data up to 12 months in a total of 1723 participants with type 1 diabetes (T1D) or type 2 diabetes (T2D) using the FreeStyle Libre® flash glucose monitoring system.ResultsOverall mean change in laboratory HbA1c across study subjects at 2–4 months was − 0.55% (95% CI − 0.70, − 0.39). Amongst the 1023 adults, mean change in HbA1c was − 0.56% (95% CI − 0.76, − 0.36); for the 447 children and adolescents, mean change in HbA1c was − 0.54% (95% CI − 0.84, − 0.23). Based on regression analysis, the degree of change in HbA1c correlated with the initial HbA1c of the study population. A longitudinal analysis in adult subjects (n = 1276) shows that HbA1c fell within the first 2 months and changes were sustained up to 12 months. No significant differences were detected between T1D and T2D.ConclusionThe meta-analysis reported here confirms that starting the FreeStyle Libre system as part of diabetes care results in a significant and sustained reduction in HbA1c for adults and children with T1D and for adults with T2D.FundingAbbott Diabetes Care.
11 schema:genre article
12 schema:isAccessibleForFree true
13 schema:isPartOf Nc78d4abe893c44cdb64d904d8d03e9a3
14 Ne10cfdbef6444a7bb8ad88de8844c483
15 sg:journal.1044057
16 schema:keywords FreeStyle Libre
17 FreeStyle Libre system
18 HbA1c
19 Libre
20 Meta-Analysis
21 ResultsOverall
22 T1D
23 adolescents
24 adult subjects
25 adults
26 analysis
27 assessment
28 care
29 care results
30 changes
31 children
32 clinical trials
33 continuous glucose monitoring
34 control
35 data
36 degree
37 degree of change
38 diabetes
39 diabetes care
40 differences
41 flash continuous glucose monitoring
42 flash glucose monitoring
43 flash glucose monitoring system
44 glucose monitoring
45 glucose monitoring system
46 glycaemic control
47 hemoglobin
48 impact
49 initial search
50 laboratory HbA1c
51 longitudinal analysis
52 measurements
53 monitoring
54 monitoring system
55 months
56 observational study
57 observed changes
58 part
59 participants
60 pediatric subjects
61 people
62 period
63 population
64 real-world observational study
65 reduction
66 regression analysis
67 reporting changes
68 results
69 search
70 significant differences
71 standard measurements
72 statistical analysis
73 study
74 study population
75 study subjects
76 subjects
77 sustained reduction
78 system
79 total
80 trials
81 types
82 schema:name The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies
83 schema:pagination 83-95
84 schema:productId N029a4faa877f4be1be7cf920d1aa623f
85 N8eaf6edf9e1a476786102c5ed7360d6f
86 N958d96216d5b45d5a0eeace6fc6fb1f7
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122231011
88 https://doi.org/10.1007/s13300-019-00720-0
89 schema:sdDatePublished 2022-09-02T16:03
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher Nafcc1264a3c242afa4a1ab33a2b6417f
92 schema:url https://doi.org/10.1007/s13300-019-00720-0
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N029a4faa877f4be1be7cf920d1aa623f schema:name dimensions_id
97 schema:value pub.1122231011
98 rdf:type schema:PropertyValue
99 N8eaf6edf9e1a476786102c5ed7360d6f schema:name doi
100 schema:value 10.1007/s13300-019-00720-0
101 rdf:type schema:PropertyValue
102 N8ef8bb9fc19f4fc38ab6a86c51402478 rdf:first sg:person.012333461330.57
103 rdf:rest Nc6b87ef112b0432194d55f5a19d37da9
104 N958d96216d5b45d5a0eeace6fc6fb1f7 schema:name pubmed_id
105 schema:value 31673972
106 rdf:type schema:PropertyValue
107 Na78c984d32dc46e586aff01b1d783656 rdf:first sg:person.0752030520.95
108 rdf:rest Nc9d97141dd67481f84d511617c12f87f
109 Nafcc1264a3c242afa4a1ab33a2b6417f schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 Nc6b87ef112b0432194d55f5a19d37da9 rdf:first sg:person.015373573342.27
112 rdf:rest rdf:nil
113 Nc78d4abe893c44cdb64d904d8d03e9a3 schema:volumeNumber 11
114 rdf:type schema:PublicationVolume
115 Nc9d97141dd67481f84d511617c12f87f rdf:first sg:person.011536100730.18
116 rdf:rest N8ef8bb9fc19f4fc38ab6a86c51402478
117 Ne10cfdbef6444a7bb8ad88de8844c483 schema:issueNumber 1
118 rdf:type schema:PublicationIssue
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
123 schema:name Clinical Sciences
124 rdf:type schema:DefinedTerm
125 sg:journal.1044057 schema:issn 1869-6953
126 1869-6961
127 schema:name Diabetes Therapy
128 schema:publisher Springer Nature
129 rdf:type schema:Periodical
130 sg:person.011536100730.18 schema:affiliation grid-institutes:None
131 schema:familyName Welsh
132 schema:givenName Zoë
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011536100730.18
134 rdf:type schema:Person
135 sg:person.012333461330.57 schema:affiliation grid-institutes:None
136 schema:familyName Ells
137 schema:givenName Sara
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012333461330.57
139 rdf:type schema:Person
140 sg:person.015373573342.27 schema:affiliation grid-institutes:None
141 schema:familyName Seibold
142 schema:givenName Alexander
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015373573342.27
144 rdf:type schema:Person
145 sg:person.0752030520.95 schema:affiliation grid-institutes:grid.24029.3d
146 schema:familyName Evans
147 schema:givenName Mark
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752030520.95
149 rdf:type schema:Person
150 sg:pub.10.1007/s00125-012-2708-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036534764
151 https://doi.org/10.1007/s00125-012-2708-9
152 rdf:type schema:CreativeWork
153 sg:pub.10.1007/s00592-018-1218-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106472592
154 https://doi.org/10.1007/s00592-018-1218-8
155 rdf:type schema:CreativeWork
156 sg:pub.10.1007/s13300-016-0223-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024814077
157 https://doi.org/10.1007/s13300-016-0223-6
158 rdf:type schema:CreativeWork
159 sg:pub.10.3758/bf03195354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025666111
160 https://doi.org/10.3758/bf03195354
161 rdf:type schema:CreativeWork
162 grid-institutes:None schema:alternateName Abbott Diabetes Care, Wiesbaden, Germany
163 Abbott Diabetes Care, Witney, Oxfordshire, UK
164 schema:name Abbott Diabetes Care, Wiesbaden, Germany
165 Abbott Diabetes Care, Witney, Oxfordshire, UK
166 rdf:type schema:Organization
167 grid-institutes:grid.24029.3d schema:alternateName Wellcome Trust/MRC Institute of Metabolic Science, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
168 schema:name Wellcome Trust/MRC Institute of Metabolic Science, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
169 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...